- Home
- SKYQ vs NERV Comparison
SKYQ vs NERV Comparison
Compare SKYQ & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYQ
- NERV
- Stock Information
- Founded
- SKYQ 2019
- NERV 2007
- Country
- SKYQ United States
- NERV United States
- Employees
- SKYQ N/A
- NERV N/A
- Industry
- SKYQ
- NERV Biotechnology: Pharmaceutical Preparations
- Sector
- SKYQ
- NERV Health Care
- Exchange
- SKYQ NYSE
- NERV Nasdaq
- Market Cap
- SKYQ 13.6M
- NERV 12.0M
- IPO Year
- SKYQ N/A
- NERV 2014
- Fundamental
- Price
- SKYQ $0.73
- NERV $1.99
- Analyst Decision
- SKYQ
- NERV Hold
- Analyst Count
- SKYQ 0
- NERV 1
- Target Price
- SKYQ N/A
- NERV $5.00
- AVG Volume (30 Days)
- SKYQ 1.1M
- NERV 15.4K
- Earning Date
- SKYQ 08-14-2025
- NERV 08-05-2025
- Dividend Yield
- SKYQ N/A
- NERV N/A
- EPS Growth
- SKYQ N/A
- NERV N/A
- EPS
- SKYQ N/A
- NERV 0.83
- Revenue
- SKYQ $18,744,825.00
- NERV N/A
- Revenue This Year
- SKYQ N/A
- NERV N/A
- Revenue Next Year
- SKYQ N/A
- NERV N/A
- P/E Ratio
- SKYQ N/A
- NERV $2.41
- Revenue Growth
- SKYQ N/A
- NERV N/A
- 52 Week Low
- SKYQ $0.48
- NERV $1.15
- 52 Week High
- SKYQ $5.49
- NERV $3.38
- Technical
- Relative Strength Index (RSI)
- SKYQ N/A
- NERV 62.90
- Support Level
- SKYQ N/A
- NERV $1.62
- Resistance Level
- SKYQ N/A
- NERV $2.32
- Average True Range (ATR)
- SKYQ 0.00
- NERV 0.14
- MACD
- SKYQ 0.00
- NERV 0.03
- Stochastic Oscillator
- SKYQ 0.00
- NERV 56.61
About SKYQ SKY QUARRY INC
Sky Quarry Inc is a development-stage oil-producing and refining company. The company, along with its subsidiaries, is engaged in deploying technologies to facilitate the recycling of waste asphalt shingles and the remediation of oil-saturated soils. The recycling and production of oil from asphalt shingles is expected to reduce the dependence on landfills for the disposal of waste and to also reduce dependence on foreign and domestic virgin crude oil extraction for industrial uses. The company has one reportable segment: refined crude oil. The company refines crude oil to produce several key products, including Diesel, Liquid Asphalt, Vacuum Gas Oil (VGO), and Naphtha, each with distinct industrial applications.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.